Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 3/20 | 0.64 |
| ▸ | CTSB | P07858 | 2/20 | 0.64 |
| ▸ | CTSS | P25774 | 2/20 | 0.64 |
| ▸ | CTSK | P43235 | 1/20 | 0.64 |
| ▸ | TACR1 | P25103 | 2/20 | 0.59 |
| ▸ | MME | P08473 | 1/20 | 0.56 |
| ▸ | ECE1 | P42892 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9557048 | 0.93 | CTSL (0.73) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL7314524 | 0.93 | CTSL (0.73) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL10521480 | 0.90 | CTSL (0.70) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL31207208 | 0.90 | CTSL (0.70) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL7350864 | 0.89 | CTSL (0.69) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL7325764 | 0.88 | CTSL (0.64) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL8583860 | 0.88 | CTSK (0.67) | CTSLCTSBCTSSCTSK | |
| SCHEMBL7325767 | 0.87 | CTSL (0.69) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL8583912 | 0.86 | TACR1 (0.61) | CTSLCTSBCTSSCTSKTACR1 | |
| SCHEMBL9127693 | 0.85 | ITGB3 (0.60) | CTSLCTSBCTSSCTSKTACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0840614-A1 | CALPAIN INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | SANOFI WINTHROP, INC. (US) | 1998-05-13 | — | — | EP | claimed |
| WO-1996041638-A1 | CALPAIN INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | SANOFI WINTHROP, INC. (US) | 1996-12-27 | — | — | WO | claimed |
| EP-0840614-A1 | CALPAIN INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | SANOFI WINTHROP, INC. (US) | 1998-05-13 | — | — | EP | disclosed |
| WO-1996041638-A1 | CALPAIN INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | SANOFI WINTHROP, INC. (US) | 1996-12-27 | — | — | WO | disclosed |
| US-5158936-A | Treating or prevention of tissue damage, inflammation, bone resporpption and muscular dystrophy | SYNTEX (U.S.A.) INC. (US) | 1992-10-27 | — | — | US | disclosed |
| US-5055451-A | Prevent tissue damage | SYNTEX INC. (US) | 1991-10-08 | — | — | US | disclosed |